The Amount of Residual Incretin Regulates the Pancreatic β-cell Function and Glucose Homeostasis

DOI Web Site PubMed 参考文献12件 オープンアクセス
  • Kondo Tatsuya
    Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Japan
  • Kitano Sayaka
    Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Japan
  • Miyakawa Nobukazu
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Watanabe Takuro
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Goto Rieko
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Sato Miki
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Hanatani Satoko
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Sakaguchi Masaji
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Igata Motoyuki
    Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Japan
  • Kawashima Junji
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Motoshima Hiroyuki
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Matsumura Takeshi
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan
  • Araki Eiichi
    Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan

この論文をさがす

抄録

<p>The gastrointestinal tract is considered an important endocrine organ for controlling glucose homeostasis via the production of incretins. A 21-year-old man emergently underwent total colectomy due to severe ulcerative colitis, and overt diabetes became evident. Weekly administration of a glucagon-like peptide (GLP)-1 receptor agonist (RA) dramatically improved his glucose control. Levels of GLP-1 or gastric inhibitory polypeptide (GIP) were low at the baseline in the duodenum and serum of the patient. After 11 months of GLP-1RA treatment, his HbA1c worsened again, and intensive insulin therapy was necessary to control his glucose levels. Our report may explain the significance of residual incretin for maintaining the pancreatic β-cell function. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 60 (9), 1433-1442, 2021-05-01

    一般社団法人 日本内科学会

参考文献 (12)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ